This company listing is no longer active
Radius Health Management
Management criteria checks 2/4
Key information
G. Martin
Chief executive officer
US$3.5m
Total compensation
| CEO salary percentage | 17.2% |
| CEO tenure | 2.3yrs |
| CEO ownership | n/a |
| Management average tenure | less than a year |
| Board average tenure | 6.8yrs |
Recent management updates
Recent updates
Radius stock rises as elacestrant gets FDA priority review to treat breast cancer subtype
Aug 11Reevaluating Radius Health
Feb 24Radius Health EPS misses by $0.02, misses on revenue
May 07When Will Radius Health, Inc. (NASDAQ:RDUS) Become Profitable?
Feb 23
Revisiting Radius Health
Feb 01Radius Health acquires global rights to RAD011 in Prader-Willi syndrome
Jan 06How Much Did Radius Health's(NASDAQ:RDUS) Shareholders Earn From Share Price Movements Over The Last Five Years?
Jan 01
Radius Health on-track for record quarterly revenue for TYMLOS-SC
Dec 15CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2022 | n/a | n/a | -US$69m |
| Mar 31 2022 | n/a | n/a | -US$73m |
| Dec 31 2021 | US$3m | US$600k | -US$70m |
| Sep 30 2021 | n/a | n/a | -US$76m |
| Jun 30 2021 | n/a | n/a | -US$60m |
| Mar 31 2021 | n/a | n/a | -US$87m |
| Dec 31 2020 | US$12m | US$413k | -US$109m |
Compensation vs Market: G.'s total compensation ($USD3.49M) is above average for companies of similar size in the US market ($USD2.61M).
Compensation vs Earnings: G.'s compensation has been consistent with company performance over the past year.
CEO
G. Martin (63 yo)
2.3yrs
Tenure
US$3,493,881
Compensation
Mr. G. Kelly Martin has been Executive Chairman of Wren Therapeutics Ltd. since 2018. Mr. Martin serves as the Chief Executive Officer, President and Director at Radius Health, Inc. since April 28, 2020.H...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$3.49m | no data | |
| VP of Sales & Head of U.S. Sales Channels | less than a year | US$741.78k | no data | |
| Senior VP & Chief Business Officer | 2.2yrs | US$1.22m | 0.27% $ 1.3m | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| VP, CFO | less than a year | no data | no data | |
| Head of Corporate Finance | no data | no data | no data | |
| Head of Investor Relations | less than a year | no data | no data | |
| General Counsel | less than a year | no data | no data | |
| Head of Corporate & Business Development | less than a year | no data | no data |
0.8yrs
Average Tenure
61.5yo
Average Age
Experienced Management: RDUS's management team is not considered experienced ( 0.8 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| CEO, President & Director | 2.3yrs | US$3.49m | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Founder | no data | no data | no data | |
| Founder & Member of the Scientific Advisory Board | no data | no data | no data | |
| Independent Director | 6.7yrs | US$544.81k | 0.045% $ 215.1k | |
| Independent Director | 2yrs | US$534.84k | 0.012% $ 55.5k | |
| Independent Director | 7.8yrs | US$536.69k | 0.037% $ 178.7k | |
| Chairman of Scientific Advisory Board | 10.5yrs | US$30.00k | no data | |
| Independent Chairman | 9.3yrs | US$832.23k | 0.034% $ 163.1k | |
| Independent Director | 7yrs | US$556.41k | 0.045% $ 215.1k | |
| Member of Scientific Advisory Board | 3.8yrs | US$1.94m | no data |
6.8yrs
Average Tenure
68.5yo
Average Age
Experienced Board: RDUS's board of directors are considered experienced (6.8 years average tenure).